Fig. 1: Overall survival and event-free survival. | Blood Cancer Journal

Fig. 1: Overall survival and event-free survival.

From: All-trans retinoic acid 45 mg/m2 is superior to 25 mg/m2 as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting

Fig. 1

A Overall survival (OS) for the whole cohort. B Event-free survival (EFS) for the whole cohort. C OS for low- or intermediate-risk patients. D EFS for low- or intermediate-risk patients. E OS for high-risk patients. F EFS for high-risk patients. G OS for patients receiving ATRA plus ATO. H EFS for patients receiving ATRA plus ATO.

Back to article page